Virios Therapeutics, Inc. VIRI 深 滬
等待開盤 09-12 09:30:00 美东时间
0.155
0.000
0.00%
華盛通- 最 高--
- 今 開--
- 成交量 0股
- 最 低 --
- 昨 收 0.155
- 總市值 298.50万
- 52周最高 26.00
- 市盈率 靜 --
- 換手率 0.00%
- 52周最低 3.15
- 委 比 0.00%
- 總股本 1925.79万
- 歷史最高 417.75
- 量 比 0
- 振 幅 0.00%
- 歷史最低 3.15
- 每 手 1
- 風險率 0.43%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Viridien commences advanced seismic imaging of Utsira North multi-client OBN survey to support exploration and development on the Norwegian Continental Shelf
Viridien has initiated the processing and imaging phase for the Utsira North multi-client Ocean Bottom Node (OBN) seismic survey in the Norwegian North Sea, following the completion of data acquisition this summer. Covering 513 square kilometers east of the Alvheim Field, the survey aims to enhance understanding of the region's complex geological features, aiding in near-field exploration and optimizing extraction in mature basins. Utilizing adva...
09-09 05:30
Viridien and TGS Announce Megabar Extension Phase I Multi-client Project Offshore Brazil
Viridien and TGS have launched the Megabar Extension Phase I survey in Brazil's Barreirinhas Basin, covering 5,300 sq km with advanced 3D seismic technology. This project aims to enhance geological understanding and exploration potential in an underexplored yet promising area, leveraging TGS’s data acquisition and Viridien’s imaging expertise. Scheduled to begin in September 2025, initial data is expected by Q3 2026, with full delivery in Q1 2027...
09-04 05:30
Virinchi Ltd. Allots 34 Lakh Convertible Equity Warrants
Virinchi Ltd. ( ($IN:VIRINCHI) ) just unveiled an update. Virinchi Ltd. has ann...
08-06 02:14
Viridien: Information on the total number of voting rights and shares
Viridien, a French société anonyme with a capital of €7,180,449, headquartered in Massy, France, reported its voting rights and share information as of July 31, 2025. The total issued shares were 7,180,449, with actual voting rights at 7,213,469 and theoretical voting rights at 7,213,718. Shares held for over two years carry double voting rights, while treasury shares have no voting rights. The figures comply with French Commercial Code and AMF r...
08-01 08:23
Viridien: 2025 Interim Financial Report available
Viridien SA published its interim financial report as of June 30, 2025, available via the AMF and accessible on its website under the Investors section. The company, specializing in advanced Earth data and technology solutions, employs around 3,400 globally and is listed on Euronext Paris ( ticker VIRI). The report highlights Viridien's contributions to natural resource, energy, and digital challenges.
07-31 17:17
Announcement of Q2 2025 Financial Results on Thursday, July 31, after market close
Viridien will announce its Q2 2025 financial results on Thursday, July 31, after market close. The press release and presentation will be available on www.viridiengroup.com at 5:45 pm CET. An English-language conference call is scheduled at 6:00 pm CET. Register via the link to receive dial-in details or join the live webcast. A replay will be available on the company’s website for 12 months. Viridien is an advanced technology company focused on ...
07-17 05:30
Viridien sets new seismic data acquisition standard with launch of Sercel Accel – the world’s first onshore drop node solution
<p>Viridien launched the Sercel Accel, the first onshore drop node solution, at the EAGE Annual Conference in Toulouse. This innovative system revolutionizes land seismic data acquisition by eliminating the need for burying nodes, reducing deployment time and labor costs by up to 30%, and significantly lowering HSE risks. Accel integrates the industry-leading QuietSeis® MEMS sensor and Pathfinder QC technology, ensuring high-quality data and reli...
06-03 05:30
Virios Therapeutics Non-GAAP EPS of -$8.45
Virios Therapeutics press release (NASDAQ:DWTX): Q1 Non-GAAP EPS of -$8.45. Cash on hand of $17.5M provides operational runway through Q1 2026. More on Virios Therapeutics Dogwood Therapeutics announc...
05-08 22:23
Virios Therapeutics GAAP EPS of -$2.05
Virios Therapeutics press release (NASDAQ:DWTX): Q3 GAAP EPS of -$2.05. The company estimates that its current cash of $2M at Sept. 30 along with the $16.5M in loan proceeds received on Oct. 7 is not ...
2024-11-07 22:55
